Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.

Source:http://linkedlifedata.com/resource/pubmed/id/12894852

Download in:

View as

General Info

PMID
12894852